The mechlorethamine (nitrogen mustard) group is shared with the alkylators cyclophosphamide and chlorambucil ... than an alkyltransferase DNA repair mechanism, suggesting that bendamustine ...
The Clean Development Mechanism (CDM), defined in Article 12 of the Protocol, allows a country with an emission-reduction or emission-limitation commitment under the Kyoto Protocol (Annex B Party) to ...
In the meanwhile, the mechanism of action of LFE against liver cancer was discussed ... which was close to the blank group. In addition, the liver tissue of cyclophosphamide group was similar to that ...
Cyclophosphamide, a DNA-alkylating agent ... by the subversion of immunosuppressive mechanisms or through direct or indirect stimulatory effects on immune effectors. Moreover, vaccination against ...
Sickle cell disease (SCD), the most common inherited blood disorder, affects millions worldwide. In the United States alone, ...
Allogene Therapeutics is undervalued. Read more on ALLO stock's cash runway, innovative CAR-T therapies, and market expansion ...
The leading AL Amyloidosis Companies such as Caelum Biosciences, Nexcella, Inc., HaemaLogiX Ltd., Prothena, ZENTALIS ...
However, the therapeutic efficacy of MMF compared with that of cyclophosphamide (CYC) in patients with AAV has not been established. We conducted a systematic review and meta-analysis to assess the ...
Q4 2024 Earnings Call Transcript February 20, 2025 Prothena Corporation plc misses on earnings expectations. Reported EPS is ...
Background Treatment strategies for Crohn’s disease (CD) suppress diverse inflammatory pathways but many patients remain ...